company of novel biopharmaceutical practices
our mission:
Expanding
access to
cutting-edge
therapies
vision:
Leading
pharmaceutical
innovations
30 years
of successful experience
news
- A Russian compound becomes the first in the world to demonstrate a significant improvement of exercise tolerance among patients with post-COVID lung injury in a multicenter randomized controlled trial
- Petrovax Pharm joins industry discussion on expanding access to innovative therapy at Forum in Uzbekistan
